Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib
Clinical trial NCT04243109 · TERMINATED
Trial details
- NCT number
- NCT04243109
- Sponsor
- Maimónides Biomedical Research Institute of Córdoba
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-23
- Primary completion
- 2019-05-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.